Publication | Closed Access

Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: Association with increased plasminogen activator inhibitor-1

ObesityThrombosisMetabolic SyndromePlasminogen Activator Inhibitor-1Cardiovascular DiseaseDiabetesImpaired Fibrinolytic CompensationType 2FibrinolysisCoagulopathyMedicineAnticoagulant